Effects of resveratrol on brain derived neurotrophic factor and neurotrophin-3 of cerebral ischemia of mice

Chinese Pharmacological Bulletin

Volumn 28, Issue 4, 2012, Pages 531-535

  Wang, Jian Ping ^a   Liu, Cong ^a   Yang, Zhi Tang ^a   Jiang, Chao ^a   Zhao, Yuan Zheng ^a   Xu, Dong Qian ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor (BDNF); Cerebral ischemia; Infarct volume; Mice; Neurotrophin 3 (NT 3); Resveratrol

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PREMEDICATION;

EID: 84863220966     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2012.04.021     Document Type: Article

References (15)

1. Raval A P, Lin H W, Dave K R, et al. Resveratrol and ischemic preconditioning in the brain[J]. Curr Med Chem, 2008,15(15):1545-51. (Pubitemid 351997786)
2. Dong W P, Zhang X, Gao D K, et al. Resveratrol's effect on acute phases of focal cerebral ischemia injury in mice[J]. Chin Pharmacol Bull, 2008,24(8):1032-5.
3. Rahvar M, Nikseresht M, Shafiee S M, et al. Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain[J]. Neurochem Res, 2011,36(5):761-5.
4. Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989,20(1):84-91. (Pubitemid 19040218)
5. Ozkan O V, Yuzbasioglu M F, Ciralik H, et al. Resveratrol, a natural anti-oxidant, attenuates intestinal ischemia/reperfusion injury in rats[J]. Tohoku J Exp Med, 2009,218(3):251-8.
6. Eybl V, Kotyzova D, Koutensky J. Comparative study of natural antioxidants-curcumin, resveratrol and melatonin-in cadmium-induced oxidative damage in mice[J]. Toxicology, 2006,225(2-3):150-6. (Pubitemid 44108372)
7. Wang Y C, Wu C, Chen H, et al. Antioxidant activities of resveratrol, oxyresveratrol, esveratrol, mulberroside A from cortex mori [J]. Shipin Kexue, 2011, 32(15):135-8.
8. Yousuf S, Atif F, Ahmad M, et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia[J]. Brain Res, 2009, 1250:242-53.
9. Della-Morte D, Dave K R, DeFazio R A, et al. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway[J]. Neuroscience, 2009,159(3); 993-1002.
10. Chen H C, Yang J S, Yang J, et al. The effect of resveratrol on expression of MMP-9 and TIMP-1 in the experimental focal cerebral ischemia[ J]. Chin J Geriatr Heart Brain Vessel Dis, 2007,9(10):703-6.
11. Vang O, Ahmad N, Baile C A, et al. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol[J]. PLoS One, 2011,6(6):e19881.
12. Yin Y Y, Li W P, Li W Z, et al. Effects of astragalosides on the expression of BDNFinverted commasTrkB and p75NTR mRNA against focal cerebral ischemia-reperfusion injury[J]. Chin Pharmacol Bull, 2009, 25(5):672-6.
13. Ikeda K, Negishi H, Yamori Y. Antioxidant nutrients and hypoxia/ischemia brain injury in rodents[J]. Toxicology, 2003,189(1-2):55-61. (Pubitemid 36725022)
14. Dmitrieva V G, Povarova O V, Skvortsova V I, et al. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia[J]. Cell Mol Neurobiol, 2010,30(1):71-9.
15. Skaper S D. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors[J]. CNS Neurol Disord Drug Targets, 2008,7(1):46-62. (Pubitemid 351516216)